Open
Imvaria 是由 Stanford/Google-team 支持的軟體醫療科技公司，專注在開發透過人工智慧賦能的數位化生物標記(Digital Biomarkers)，軟體結合醫療影像和實驗室數據，將應用在嚴重和罕見疾病。目前首要關注肺部、肝臟、腎臟和癌症等領域，本團隊期待可以利用數位化生物標記提高嚴重疾病的早期診斷率。
IMVARIA's lead digital biomarker, Fibresolve, demonstrates the power of IMVARIA's innovation to serve as adjunct in assessment of interstitial lung disease (ILD) including idiopathic pulmonary fibrosis (IPF), potentially avoiding expensive, invasive surgical testing.* Fibresolve uses AI to analyze CT imaging for specific, novel patterns.
IMVARIA's lead digital biomarker, Fibresolve, demonstrates the power of IMVARIA's innovation to serve as adjunct in assessment of interstitial lung disease (ILD) including idiopathic pulmonary fibrosis (IPF), potentially avoiding expensive, invasive surgical testing.* Fibresolve uses AI to analyze CT imaging for specific, novel patterns.